Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
![]() |
Effectiveness of bevacizumab added to standard chemotherapy in metastatic colorectal cancer: final results for first-line treatment from the ITACa randomized clinical trialPassardi, A. ; Nanni, O. ; Tassinari, D. ; Turci, D. ; Cavanna, L. ; Fontana, A. ; Ruscelli, S. ; Mucciarini, C. ; Lorusso, V. ; Ragazzini, A. ; Frassineti, G.L. ; Amadori, D.Annals of oncology, 2015-06, Vol.26 (6), p.1201-1207 [Peer Reviewed Journal]England: Elsevier LtdFull text available |
2 |
Material Type: Article
|
![]() |
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancerVrdoljak, E. ; Marschner, N. ; Zielinski, C. ; Gligorov, J. ; Cortes, J. ; Puglisi, F. ; Aapro, M. ; Fallowfield, L. ; Fontana, A. ; Inbar, M. ; Kahan, Z. ; Welt, A. ; Lévy, C. ; Brain, E. ; Pivot, X. ; Putzu, C. ; González Martín, A. ; de Ducla, S. ; Easton, V. ; von Minckwitz, G.Annals of oncology, 2016-11, Vol.27 (11), p.2046-2052 [Peer Reviewed Journal]England: Elsevier LtdFull text available |